Skip to main content
. Author manuscript; available in PMC: 2011 Jul 15.
Published in final edited form as: Bioorg Med Chem. 2010 Jun 1;18(14):5114–5122. doi: 10.1016/j.bmc.2010.05.068

Table 2.

Inhibition of tubulin polymerization and colchicine binding by compounds 3c–d, 4b, 4e–g, 4i–j, 4l–m and CA4

Compound Tubulin assemblya
IC50 ± SD (µM)
Colchicine
bindingb % ± SD

1 µM
drug
5 µM
drug
3c 1.3 ±0.1 60 ± 0.1 n.d.
3d 2.1 ± 0.3 39 ± 1 n.d.
4b 1.2 ± 0.07 49 ± 1 81 ±4
4e 0.58 ± 0.02 60 ± 0.3 88 ± 0.5
4f 0.63 ± 0.1 51 ± 2 88 ± 4
4g 0.67 ± 0.1 85 ± 7 93 ± 5
4i 0.92 ± 0.05 66 ± 4 92 ± 0.3
4j 0.95 ± 0.06 54 ± 3 87 ± 1
4l 0.93 ± 0.01 n.d. 75 ± 3
4m 0.71 ± 0.1 48 ± 2 80 ± 1
CA4 (1) 1.0 ± 0.09 88 ± 1 99 ± 2

n.d.: not determined.

a

Inhibition of tubulin polymerization. Tubulin was at 10 µM.

b

Inhibition of [3H]colchicine binding. Tubulin was at 1 µM, colchicine was at 5 µM.